Clinical Trials Browser

Completed × Observational × spartalizumab × Clear all

NCT06298123 2024-03-07

Postoperative Adjuvant Immunotherapy for Hepatocellular Carcinoma: Risk Factor Analysis and Prognostic Modelling

Gastrointestinal

Carcinoma, Hepatocellular